OPKO Health acquires 10% stake in Pharmsynthez - MarketLine Financial Deals

OPKO Health acquires 10% stake in Pharmsynthez

OPKO Health acquires 10% stake in Pharmsynthez - MarketLine Financial Deals
OPKO Health acquires 10% stake in Pharmsynthez
Published Apr 18, 2013
2 pages — Published Apr 18, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

OPKO Health, Inc., a US-based biopharmaceutical and diagnostics company, has acquired an approximate 10% stake in Pharmsynthez OJSC.

  
Source:
Document ID
MA138298_130422
Country
Country
Ticker
OPK=US
Ticker
LIFE=RU
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "OPKO Health acquires 10% stake in Pharmsynthez" Apr 18, 2013. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/OPKO-Health-acquires-10-stake-in-Pharmsynthez-2052-93846>
  
APA:
MarketLine Financial Deals. (2013). OPKO Health acquires 10% stake in Pharmsynthez Apr 18, 2013. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/OPKO-Health-acquires-10-stake-in-Pharmsynthez-2052-93846>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.